Sales and Marketing

News

Hands with the world painted on the palms, cloud filled blue sky in the background

Lundbeck retreats from dozens of markets, slashing staff

Lundbeck has announced a major change to its commercial strategy, withdrawing from 27 markets and handing day-to-day operations to partners.

News

Alzheimer's drug Leqembi launched in first EU markets

Germany and Austria are the first countries in the EU to see the launch of Leqembi, Eisai and Biogen's much-delayed treatment for Alzheimer's.

News

Iterum brings first oral penem antibiotic to US market

Iterum has launched Orlynvah as a treatment for uncomplicated urinary tract infections (uUTIs), the first oral option in the go-to penem class.

News

CSL will slash headcount and hive off vaccine business

Facing declines in flu vaccination rates in the US, CSL will spin out its vaccine unit as part of a wider restructuring that will claim 3,000 jobs.

Digital

How consumer data is redefining HCP engagement

The way brands engage healthcare providers (HCPs) is undergoing a seismic shift in today’s digital-first healthcare ecosystem. The sales rep model is fading.

News

Novo Nordisk cuts GLP-1 prices for cash buyers

Novo Nordisk has said it will offer diabetes therapy Ozempic at $499 per month for cash-paying customers in the US.

Lundbeck retreats from dozens of markets, slashing staff

Alzheimer's drug Leqembi launched in first EU markets

Iterum brings first oral penem antibiotic to US market

CSL will slash headcount and hive off vaccine business

How consumer data is redefining HCP engagement

Novo Nordisk cuts GLP-1 prices for cash buyers

Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer

Discover a new era of healthcare panel engagement: Grounded ...

Sales and Marketing

Editor's Picks